Join us and together let's bring life-saving solutions to ischaemic stroke patients across the APAC region. If you are interested in partnering with us, please contact us directly at [email protected] 📩. iVascular neurointerventionism portfolio: •iNedit: Balloon distal access catheter •iNtercept: stent retriever •iNdeep: Microcatheter •iNstroke: Thrombus extractor Want to learn more about our full portfolio? ➡ visit https://ivascular.global/
Info
The purpose of iVascular is to develop innovative advanced medical devices and therapies for the treatment of disorders of the cardiovascular system. Its staff has extensive knowledge of biopolymers, coatings, drug delivery, mechanical engineering, medicine and pharmacy. They bring together recognised experience in the development of medical devices and implants. Thanks to the know-how provided by our scientists and technicians and an appropriate investment in technology, iVascular has implemented a vertical integration project allowing it to develop, innovate and produce cardiovascular devices from basic raw materials (plastics, polymers, metals, etc.) to the final device or implant. iVascular possesses and develops its own technologies, which have made possible the vertical integration of each and every one of the processes involved in developing a device, from the earliest design stages through to final production. In this way we guarantee the highest quality standards in all our products. iVascular has a technology center with more than 1000 m² of clean rooms (ISO 7 and ISO 8) and 250 m² of R&D laboratories equipped with the most comprehensive, advanced instrumentation in the biotechnology field. Through its direct and indirect sales network, iVascular is present in more than 70 countries around the world, and is providing with full range of products for interventional cardiology and endovascular procedures. For more information about iVascular, please, visit www.ivascular.global or If you have any questions or comments, we are ready to help you out by an e-mail to [email protected]
- Website
-
http://www.ivascular.global
Externer Link zu iVascular
- Branche
- Herstellung medizinischer Geräte
- Größe
- 201–500 Beschäftigte
- Hauptsitz
- Freiburg im Breisgau
- Kunst
- Personengesellschaft (OHG, KG, GbR etc.)
- Gegründet
- 2010
- Spezialgebiete
- Medical Devices, Polymer Science, Drug Delivery, Cardiovascular devices, Endovascular, Interventional Cardiology, Drug Eluting Stent und Drug Coated Balloon
Orte
Beschäftigte von iVascular
Aktualisierungen
-
Have you explored our portfolio for ischemic stroke? Dive into the world of innovative solutions, including microcatheters, stent retrievers, and groundbreaking offerings like iNedit, our distal balloon catheter. Full portfolio: https://ivascular.global/ #iVascular #MedicalInnovation #IschemicStroke #Neurointerventionism
-
Remarkable results of the SOL Japan trial featuring the #LuminorDCB in the Japanese population. At 12 months, Dr Soga (PI) described the outcomes as "awesome," achieving a primary patency of 94.9% and freedom from target lesion revascularization of 99.2%. These figures underscore the effectiveness of Luminor DCB. #iVascular #Endovascular #MedicalInnovation
-
Don't miss your chance to participate in #iCardioGrant2024! Submit your clinical case using at least two iVascular devices for an opportunity to enhance your medical knowledge and contribute to the field of interventional cardiology. Find out all the details here ➡️ https://lnkd.in/eAx7p9j2 #iCardioGrant #MedicalEducation #CTO
-
Ready to elevate your skills in chronic total occlusions? Our CiCTO course has already seen tremendous success with 2 editions this year – one for LATAM and one for MEA, each with 12 enthusiastic participants! In the meantime, dive into #Navitian's 16 clinical cases showcasing complex challenges and solutions ➡️ https://lnkd.in/dqVqeqSu Don't miss out on the next edition – join us and expand your expertise in CiCTO! 💼👩⚕️👨⚕️ #CiCTO #HealthcareEducation #ChronicTotalOcclusions
-
Time is running out to submit your endovascular clinical case for the #iVascularGrant 2024! Showcase your innovative work and win the opportunity to participate in our educational program. Don't think twice and submit your case today ➡️https://lnkd.in/ed6p5aTa #iVascular #iVascularGrant #Endovascular #MedicalEducation
-
Real-world evidence of Essential pro DCB has been recently published. This evidence highlighted the safety and efficacy of Essential Pro in treating coronary in-stent restenosis (ISR). The outcomes were published by the PI Dr Lucio T Padilla MD et al in REC: Interventional Cardiology. Read the full press release for more details
iVascular Essential Pro DCB Studied in Treatment of Coronary ISR
-
We are excited to share the 1st iCover BX covered stent case in Thailand! Dr Nantiskarn Chanpen and Dr Pawanrat Kranokpiraksa from King Chulalongkorn Memorial Hospital have successfully implanted an iCover in an AIOD case. The doctors highlighted the stent's visibility, navigability, small profile, and low shortening. This achievement significantly advances our efforts to provide cutting-edge medical solutions in Thailand with our partners at Vas Innovative. #InnovationInHealthcare #MedicalBreakthrough #HealthTech
-
iVascular is present in more than 70 countries worldwide, but our journey doesn't stop there! With the culmination of our new facilities, our production will be increased x6 times 🌍🏢 Our goal? To provide specialists worldwide with high quality devices. #iVascularExpansion #GlobalGrowth
-
First outcomes of SOL Japan Trial featuring Luminor DCB have been impressive. At 12 months, the PI Dr Soga, has described the results as “awesome” with a PP 94.9% and fTLR 99.2%, proving that Luminor offers higher primary patency and low TLR, with no safety concerns. Do you want to learn more about Luminor’s features? ➡️ https://lnkd.in/d3sfKuCk #iVascular #LuminorDCB #endovascular